Abiopharma

Agiri Oluwagbemileke Yusuf 🔴 sold 1.7K shares of Gevo, Inc. (GEVO) at $1.63 Transaction Date: Sep 04, 2025 | Filing ID: 023811

Bloom Paul D 🔴 sold 2.1K shares of Gevo, Inc. (GEVO) at $1.63 Transaction Date: Sep 04, 2025 | Filing ID: 023810

Ryan Christopher Michael 🔴 sold 1.7K shares of Gevo, Inc. (GEVO) at $1.63 Transaction Date: Sep 04, 2025 | Filing ID: 023807

New Form 8-K/A - TNF Pharmaceuticals, Inc. Filed: 2025-09-05 AccNo: 0001641172-25-026762 Size: 1 MB Item 9.01: Financial Statements and Exhibits

Gruber Patrick R. 🔴 sold 1.6K shares of Gevo, Inc. (GEVO) at $1.63 Transaction Date: Sep 04, 2025 | Filing ID: 023806

New Form D - TNF Pharmaceuticals, Inc. Filed: 2025-09-05 AccNo: 0001641172-25-026761 Size: 14 KB

New Form 8-K - BioSig Technologies, Inc. Filed: 2025-09-05 AccNo: 0001641172-25-026749 Size: 481 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 5.07: Submission …

New Form 8-K - Emergent BioSolutions Inc. Filed: 2025-09-05 AccNo: 0001367644-25-000183 Size: 1 MB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form SCHEDULE 13D/A - Alaunos Therapeutics, Inc. Filed: 2025-09-05 AccNo: 0001213900-25-085149 Size: 11 KB

Director Gilboa David Abraham 🟡 adjusted position in 1.7M shares (5 derivative) of Warby Parker Inc. (WRBY) at $25.55 Transaction Date: Sep 03, 2025 | Filing ID: 087903